Matthew J. Akiyama

1.9k total citations
101 papers, 1.2k citations indexed

About

Matthew J. Akiyama is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Matthew J. Akiyama has authored 101 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 69 papers in Epidemiology, 61 papers in Hepatology and 35 papers in Infectious Diseases. Recurrent topics in Matthew J. Akiyama's work include Hepatitis C virus research (61 papers), HIV, Drug Use, Sexual Risk (48 papers) and Hepatitis B Virus Studies (34 papers). Matthew J. Akiyama is often cited by papers focused on Hepatitis C virus research (61 papers), HIV, Drug Use, Sexual Risk (48 papers) and Hepatitis B Virus Studies (34 papers). Matthew J. Akiyama collaborates with scholars based in United States, Kenya and Canada. Matthew J. Akiyama's co-authors include Anne C. Spaulding, Josiah D. Rich, Alain H. Litwin, Brianna L. Norton, Moonseong Heo, Linda Agyemang, Julia H. Arnsten, Ross MacDonald, Nadine Kronfli and Zachary Rosner and has published in prestigious journals such as New England Journal of Medicine, JAMA and Circulation.

In The Last Decade

Matthew J. Akiyama

87 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Matthew J. Akiyama United States 19 694 602 371 187 172 101 1.2k
Catherine R. McGowan United Kingdom 14 616 0.9× 450 0.7× 345 0.9× 54 0.3× 175 1.0× 40 1.1k
Phillip Read Australia 23 853 1.2× 522 0.9× 481 1.3× 150 0.8× 208 1.2× 88 1.5k
Éamonn O’Moore United Kingdom 15 349 0.5× 147 0.2× 219 0.6× 296 1.6× 213 1.2× 40 858
Fortune Ncube United Kingdom 22 855 1.2× 460 0.8× 359 1.0× 128 0.7× 78 0.5× 54 1.3k
A. D. McNaghten United States 22 932 1.3× 200 0.3× 1.1k 2.9× 189 1.0× 322 1.9× 40 1.5k
Jane Parry United Kingdom 17 553 0.8× 328 0.5× 247 0.7× 126 0.7× 94 0.5× 50 891
Nick Walsh Australia 17 736 1.1× 541 0.9× 262 0.7× 37 0.2× 64 0.4× 42 950
Winston E. Abara United States 20 442 0.6× 149 0.2× 530 1.4× 187 1.0× 147 0.9× 55 1.2k
Henry Roberts United States 14 678 1.0× 476 0.8× 140 0.4× 46 0.2× 220 1.3× 27 1.0k
Colette Smit Netherlands 16 782 1.1× 308 0.5× 912 2.5× 53 0.3× 94 0.5× 49 1.6k

Countries citing papers authored by Matthew J. Akiyama

Since Specialization
Citations

This map shows the geographic impact of Matthew J. Akiyama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew J. Akiyama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew J. Akiyama more than expected).

Fields of papers citing papers by Matthew J. Akiyama

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew J. Akiyama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew J. Akiyama. The network helps show where Matthew J. Akiyama may publish in the future.

Co-authorship network of co-authors of Matthew J. Akiyama

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew J. Akiyama. A scholar is included among the top collaborators of Matthew J. Akiyama based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew J. Akiyama. Matthew J. Akiyama is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Akiyama, Matthew J., et al.. (2025). Barriers to and impacts of hepatitis C treatment among people who inject drugs in Kenya: A qualitative study. PLOS Global Public Health. 5(1). e0003284–e0003284.
2.
Sheehan, Yumi, Akhil Garg, Frederick L. Altice, et al.. (2025). Best practice guidelines for viral hepatitis service delivery in prisons. The Lancet Infectious Diseases. 1 indexed citations
3.
Walker, Josephine G., Matthew J. Akiyama, Andreea Adelina Artenie, et al.. (2025). Impact of scaling up harm reduction interventions on injecting risk behaviours, ART outcomes and HIV incidence among people who inject drugs in Kenya. International Journal of Drug Policy. 140. 104824–104824.
4.
Walker, Shelley, Lok Bahadur Shrestha, Andrew R. Lloyd, et al.. (2024). Barriers and advocacy needs for hepatitis C services in prisons: Informing the prisons hepatitis C advocacy toolkit. International Journal of Drug Policy. 126. 104386–104386. 7 indexed citations
5.
6.
Akiyama, Matthew J., Yury Khudyakov, Sumathi Ramachandran, et al.. (2024). Widespread hepatitis C virus transmission network among people who inject drugs in Kenya. International Journal of Infectious Diseases. 147. 107215–107215.
7.
Akiyama, Matthew J., et al.. (2024). Policies for Expanding Hepatitis C Testing and Treatment in United States Prisons and Jails. University of Michigan Journal of Law Reform. 1–1. 1 indexed citations
8.
Pericot‐Valverde, Irene, Moonseong Heo, Brianna L. Norton, et al.. (2024). Distrust in the Health Care System and Adherence to Direct-Acting Antiviral Therapy among People with Hepatitis C Virus Who Inject Drugs. Viruses. 16(8). 1304–1304.
9.
Kronfli, Nadine, Giada Sebastiani, Marina B. Klein, et al.. (2024). Perceived patient navigator services and characteristics to address barriers to linkage to hepatitis C care among people released from provincial prison in Quebec, Canada. International Journal of Drug Policy. 133. 104624–104624. 3 indexed citations
10.
Akiyama, Matthew J., Helgar Musyoki, Chenshu Zhang, et al.. (2023). Predictors of hepatitis C cure among people who inject drugs treated with directly observed therapy supported by peer case managers in Kenya. International Journal of Drug Policy. 113. 103959–103959. 2 indexed citations
11.
12.
Wang, Yuke, Tylis Y. Chang, Pengbo Liu, et al.. (2023). Correlation of SARS-CoV-2 in Wastewater and Individual Testing Results in a Jail, Atlanta, Georgia, USA. Emerging infectious diseases. 30(13). S21–S27. 2 indexed citations
13.
Stone, Jack, Hannah Fraser, Josephine G. Walker, et al.. (2022). Modelling the impact of HIV and hepatitis C virus prevention and treatment interventions among people who inject drugs in Kenya. AIDS. 36(15). 2191–2201. 6 indexed citations
14.
Diaz, Chanelle, et al.. (2022). Harmful by Design—a Qualitative Study of the Health Impacts of Immigration Detention. Journal of General Internal Medicine. 38(9). 2030–2037. 11 indexed citations
15.
Akiyama, Matthew J., Helgar Musyoki, Chenshu Zhang, et al.. (2022). Hepatitis C treatment outcomes among people who inject drugs accessing harm reduction settings in Kenya. Journal of Viral Hepatitis. 29(8). 691–694. 5 indexed citations
16.
Fung, Isaac Chun‐Hai, et al.. (2021). Aiming for Zero: Reducing Transmission of Coronavirus Disease 2019 in the D.C. Department of Corrections. Open Forum Infectious Diseases. 8(12). ofab547–ofab547. 5 indexed citations
17.
Akiyama, Matthew J., et al.. (2021). Hepatitis C-related knowledge, attitudes and perceived risk behaviours among people who inject drugs in Kenya: A qualitative study. Global Public Health. 17(6). 1016–1028. 10 indexed citations
18.
Akiyama, Matthew J., et al.. (2021). HIV And HCV adherence and treatment outcomes among people who inject drugs receiving opioid agonist therapy. AIDS Care. 34(10). 1229–1233. 2 indexed citations
19.
Ross, Jonathan, Matthew J. Akiyama, Deepika E. Slawek, et al.. (2019). Undocumented African Immigrants' Experiences of HIV Testing and Linkage to Care. AIDS Patient Care and STDs. 33(7). 336–341. 16 indexed citations
20.
Akiyama, Matthew J., et al.. (1978). [Studies of shock produced by superior mesenteric artery occlusion--changes of adrenocortical hormones (author's abstract)].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 27(4). 343–8. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Catherine R. McGowan Breakdown of academic impact, for papers by Phillip Read Breakdown of academic impact, for papers by Éamonn O’Moore Breakdown of academic impact, for papers by Fortune Ncube Breakdown of academic impact, for papers by A. D. McNaghten Breakdown of academic impact, for papers by Jane Parry Breakdown of academic impact, for papers by Nick Walsh Breakdown of academic impact, for papers by Winston E. Abara Breakdown of academic impact, for papers by Henry Roberts Breakdown of academic impact, for papers by Colette Smit
Rankless by CCL
2026